Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: Occurrence and prognostic value when comparing three response criteria

European Heart Journal

Volumn 32, Issue 24, 2011, Pages 3137-3146

  Douwes, Johannes M ^a   Van Loon, Rosa L E ^a   Hoendermis, Elke S ^b   Vonk Noordegraaf, Anton ^c   Roofthooft, Marcus T R ^a   Talsma, Melle D ^a   Hillege, Hans L ^b   Berger, Rolf M F ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute pulmonary vasodilator response; Congenital heart disease; Haemodynamics; Heart catheterization; Pulmonary arterial hypertension; Survival

Indexed keywords

ACUTE VASODILATOR RESPONSE; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTERIAL PRESSURE; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD DISEASE; CLINICAL PRACTICE; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; FEMALE; HEART RIGHT ATRIUM PRESSURE; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION; INFANT; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTEMIC VASCULAR RESISTANCE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; VASODILATION; VASODILATOR AGENTS;

EID: 83755185625     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr282     Document Type: Article

References (22)

1. Tuder RM, Abman SH, Braun T, Capron F, Stevens T, Thistlethwaite PA, Haworth SG. Development and Pathology of Pulmonary Hypertension. J Am Coll Cardiol 2009;54:S3-S9.
2. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing Z, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-S54.
3. Authors/Task Force Members, Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-2537.
4. Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999;99:1197-1208.
5. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
6. Raffy O, Azarian R, Brenot F, Parent F, Sitbon O, Petitpretz P, Herve P, Duroux P, Dinh-Xuan AT, Simonneau G. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation 1996;93:484-488.
7. Berner M, Beghetti M, Spahr-Schopfer I, Oberhansli I, Friedli B. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease. Am J Cardiol 1996;77:532-535. (Pubitemid 26086648)
8. Berger RM. Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects. Eur Heart J 2000;21:17-27. (Pubitemid 30042664)
9. Barst RJ. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. Chest 1986;89:497-503. (Pubitemid 16133708)
10. Sitbon O, Humbert M, Jais X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Herve P, Simonneau G. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;111:3105-3111. (Pubitemid 40847788)
11. Rosenzweig EB, Widlitz AC, Barst RJ. Pulmonary arterial hypertension in children. Pediatr Pulmonol 2004;38:2-22. (Pubitemid 38823753)
12. Costa EL, Jardim C, Bogossian HB, Amato MB, Carvalho CR, Souza R. Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Vascul Pharmacol 2005;43:143-147. (Pubitemid 41160466)
13. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007;30:1103-1110. (Pubitemid 351194756)
14. van Loon RL, Roofthooft MT, Osch-Gevers M, Delhaas T, Strengers JL, Blom NA, Backx A, Berger RM. Clinical characterization of pediatric pulmonary hypertension: complex presentation and diagnosis. J Pediatr 2009;155:176-182.
15. LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res 1970;4:23-30.
16. Krovetz LJ, Goldbloom S. Normal standards for cardiovascular data. I. Examination of the validity of cardiac index. Johns Hopkins Med J 1972; 130:174-186.
17. Pauli C, Fakler U, Genz T, Hennig M, Lorenz HP, Hess J. Cardiac output determination in children: equivalence of the transpulmonary thermodilution method to the direct Fick principle. Intensive Care Med 2002;28:947-952. (Pubitemid 34762232)
18. Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Heart 2008;94(Suppl. 1):i1-41.
19. Budts W, Van Pelt N, Gillyns H, Gewillig M, Werf VD, Janssens S. Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome. Heart 2001;86: 553-558. (Pubitemid 32999869)
20. Limsuwan A, Khosithseth A,Wanichkul S, Khowsathit P. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Catheter Cardiovasc Interv 2009;73:98-104.
21. van Loon RL, Roofthooft MT, Delhaas T, van Osch-Gevers M, ten Harkel AD, Strengers JL, Backx A, Hillege HL, Berger RM. Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. Am J Cardiol 2010;106:117-124.
22. Kanemoto N. Natural history of pulmonary hemodynamics in primary pulmonary hypertension. Am Heart J 1987;114:407-413. (Pubitemid 17131736)